Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (211-220 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Infectious Diseases|October 6, 2005
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 diseaseRobert C Kalayjian, John Spritzler, Minya Pu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248)Mary A Vogler, Hedy Teppler, Rebecca Gelman, et al.
The Journal of Infectious Diseases|December 17, 2015
SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial DysfunctionSoumya Panigrahi, Michael L Freeman, Nicholas T Funderburg, et al.
Journal of Virology|July 25, 2014
Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosisLumin Zhang, Zhenwu Luo, Scott F Sieg, et al.
The Journal of Infectious Diseases|February 15, 2023
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1Eva Poveda, Wendy Fitzgerald, Cristina Reglero, et al.
Frontiers in Immunology|July 11, 2022
Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical TrialMariana Araújo-Pereira, Beatriz Barreto-Duarte, María B Arriaga, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2016
Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV InfectionSadeer G Al-Kindi, Chang H Kim, Stephen R Morris, et al.
The Journal of Infectious Diseases|March 23, 2017
Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral TherapySulggi Lee, Helen Byakwaga, Yap Boum, et al.
Plos One|February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersGareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
International Journal of Epidemiology|February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsMari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
Pageof 31

Showing results (211-220 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|October 6, 2005
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 diseaseRobert C Kalayjian, John Spritzler, Minya Pu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248)Mary A Vogler, Hedy Teppler, Rebecca Gelman, et al.
The Journal of Infectious Diseases|December 17, 2015
SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial DysfunctionSoumya Panigrahi, Michael L Freeman, Nicholas T Funderburg, et al.
Journal of Virology|July 25, 2014
Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosisLumin Zhang, Zhenwu Luo, Scott F Sieg, et al.
The Journal of Infectious Diseases|February 15, 2023
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1Eva Poveda, Wendy Fitzgerald, Cristina Reglero, et al.
Frontiers in Immunology|July 11, 2022
Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical TrialMariana Araújo-Pereira, Beatriz Barreto-Duarte, María B Arriaga, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2016
Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV InfectionSadeer G Al-Kindi, Chang H Kim, Stephen R Morris, et al.
The Journal of Infectious Diseases|March 23, 2017
Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral TherapySulggi Lee, Helen Byakwaga, Yap Boum, et al.
Plos One|February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersGareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
International Journal of Epidemiology|February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsMari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
Pageof 31